FB2026_03 , released September 17, 2026
Reference Report
Open Close
Reference
Citation
Meraner, P., Avetisyan, A., Swift, K., Cheng, Y.C., Barria, R., Freeman, M.R. (2026). Hypoxia-inducible factor 1 protects neurons from Sarm1-mediated neurodegeneration.  Cell Rep. 45(2): 116873.
FlyBase ID
FBrf0264726
Publication Type
Research paper
Abstract
The sterile alpha and TIR motif-containing 1 (Sarm1) NAD[+] hydrolase drives neurodegeneration, but how Sarm1 activity is regulated remains poorly defined. Using CRISPR-Cas9 screening, we found that loss of Vhl suppressed Sarm1-mediated cellular degeneration. Vhl promotes O2-dependent constitutive ubiquitination and degradation of hypoxia-inducible factor 1 (HIF-1), but during hypoxia, HIF-1 is stabilized and regulates gene expression. We observed neuroprotection in primary neurons after depletion of Vhl or other factors required for HIF-1 degradation, and expression of a non-ubiquitinated HIF-1 variant led to strong blockade of axon degeneration in primary mouse neurons and Drosophila. Neuroprotection required HIF-1 DNA binding and prolonged expression and resulted in broad gene expression changes. Unexpectedly, stabilized HIF-1 prevented NAD[+] loss driven by Sarm1 activation in neurons, despite NAD+ hydrolase activity being intrinsic to the Sarm1 TIR domain. Our work argues that hypoxia inhibits Sarm1 activity through HIF-1-driven transcriptional changes, rendering neurons in a hypoxic state less sensitive to Sarm1-mediated neurodegeneration.
PubMed ID
PubMed Central ID
Associated Information
Comments
Associated Files
Other Information
Secondary IDs
    Language of Publication
    English
    Additional Languages of Abstract
    Parent Publication
    Publication Type
    Journal
    Abbreviation
    Cell Rep.
    Title
    Cell reports
    ISBN/ISSN
    2211-1247
    Data From Reference